Scarica l'app Stockscreener
5.15
3.41%
0.17
Dopo l'orario di chiusura:
5.13
-0.02
-0.39%
Precedente Chiudi:
$4.98
Aprire:
$4.94
Volume 24 ore:
73,775
Relative Volume:
0.73
Capitalizzazione di mercato:
$256.82M
Reddito:
$15.33M
Utile/perdita netta:
$-40.19M
Rapporto P/E:
-2.9392
EPS:
-1.7522
Flusso di cassa netto:
-
1 W Prestazione:
+0.78%
1M Prestazione:
+22.62%
6M Prestazione:
-9.65%
1 anno Prestazione:
+2.79%
Intervallo 1D:
$4.86
$5.17
Intervallo di 1 settimana:
$4.80
$5.30
Portata 52W:
$3.42
$5.88
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
Nome
Trisalus Life Sciences Inc
Settore
Industria
Telefono
415 336 8917
Indirizzo
6272 WEST 91ST AVENUE, WESTMINSTER
Confronta TLSI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.15 | 257.32M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-11-11 | Iniziato | ROTH MKM | Buy |
| 2024-10-25 | Iniziato | Northland Capital | Outperform |
| 2024-09-16 | Iniziato | Oppenheimer | Outperform |
| 2024-05-30 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Trisalus Life Sciences Inc Borsa (TLSI) Ultime notizie
Will a bounce in TriSalus Life Sciences Inc. Equity Warrant offer an exitTrade Exit Report & Weekly High Conviction Trade Ideas - Newser
What does recent volatility data suggest for TriSalus Life Sciences Inc.Portfolio Gains Report & Daily Stock Trend Reports - Newser
Will TriSalus Life Sciences Inc. bounce back from current supportMarket Performance Summary & Low Risk High Win Rate Stock Picks - Newser
How to build a custom watchlist for TriSalus Life Sciences Inc.Weekly Stock Summary & High Conviction Buy Zone Picks - Newser
Will TriSalus Life Sciences Inc. stock go up soonJuly 2025 Reactions & Weekly Hot Stock Watchlists - Newser
Comparing TriSalus Life Sciences Inc. Equity Warrant in custom built stock radarsPortfolio Growth Summary & Community Shared Stock Ideas - Newser
Technical analysis overview for TriSalus Life Sciences Inc. stockWeekly Loss Report & Safe Capital Growth Tips - Newser
Candlestick signals on TriSalus Life Sciences Inc. Equity Warrant stock todayQuarterly Portfolio Report & Consistent Growth Stock Picks - Newser
Risk adjusted return profile for TriSalus Life Sciences Inc. analyzedJuly 2025 Big Picture & Weekly Top Gainers Alerts - Newser
What the charts say about TriSalus Life Sciences Inc. todayJuly 2025 Macro Moves & Capital Protection Trading Alerts - Newser
Published on: 2025-09-03 02:39:11 - Newser
Is TriSalus Life Sciences Inc. Equity Warrant meeting your algorithmic filter criteriaJuly 2025 Opening Moves & Risk Controlled Swing Trade Alerts - Newser
Key resistance and support levels for TriSalus Life Sciences Inc.Entry Point & Daily Oversold Bounce Ideas - Newser
Does TriSalus Life Sciences Inc. outperform in volatile marketsJuly 2025 Analyst Calls & Safe Entry Point Identification - khodrobank.com
Combining price and volume data for TriSalus Life Sciences Inc. Equity Warrant2025 Top Gainers & Verified Entry Point Signals - Newser
Does TriSalus Life Sciences Inc. have pricing powerWeekly Investment Summary & Community Consensus Picks - khodrobank.com
Visual analytics tools that track TriSalus Life Sciences Inc. performance2025 Bull vs Bear & Safe Swing Trade Setups - Newser
How to integrate TriSalus Life Sciences Inc. into portfolio analysis toolsQuarterly Portfolio Report & Low Volatility Stock Recommendations - Newser
Real time pattern detection on TriSalus Life Sciences Inc. Equity Warrant stockWeekly Risk Summary & Scalable Portfolio Growth Methods - Newser
Is TriSalus Life Sciences Inc. Equity Warrant undervalued by DCF analysisJuly 2025 Levels & Real-Time Stock Price Movement Reports - khodrobank.com
Reversal indicators forming on TriSalus Life Sciences Inc. Equity Warrant stockDip Buying & Technical Confirmation Trade Alerts - Newser
Should I invest in TriSalus Life Sciences Inc. before earningsQuarterly Trade Summary & Low Risk Profit Maximizing Plans - khodrobank.com
Custom watchlist performance reports with TriSalus Life Sciences Inc.Options Play & Low Volatility Stock Recommendations - Newser
Is TriSalus Life Sciences Inc. part of any ETF2025 Sector Review & Daily Growth Stock Tips - khodrobank.com
How TriSalus Life Sciences Inc. stock performs during market volatilityOil Prices & Capital Protection Trade Alerts - Newser
How to track smart money flows in TriSalus Life Sciences Inc.Weekly Gains Summary & Risk Managed Trade Strategies - Newser
Is TriSalus Life Sciences Inc. a cyclical or defensive stock2025 Valuation Update & Precise Trade Entry Recommendations - khodrobank.com
What the charts say about Credit Acceptance Corporation todayJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser
Uveal Melanoma Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Novartis, Foghorn Therapeutics Inc., TriSalus Life Sciences, Inc., AstraZeneca - The Globe and Mail
Predicting TriSalus Life Sciences Inc. trend using moving averagesPortfolio Return Summary & Safe Capital Growth Stock Tips - Newser
Trapped Investors in TriSalus Life Sciences Inc. Await Breakout Signal getLinesFromResByArray error: size == 0 - thegnnews.com
Comparing TriSalus Life Sciences Inc. in custom built stock radarsStock Surge & Free High Accuracy Swing Entry Alerts - Newser
Detecting price anomalies in TriSalus Life Sciences Inc. with AI2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Is this a good reentry point in TriSalus Life Sciences Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Weekly Trades: Can TriSalus Life Sciences Inc. Equity Warrant navigate macro headwinds2025 Key Lessons & Weekly Momentum Picks - khodrobank.com
Can swing trading help recover from TriSalus Life Sciences Inc. losses2025 Earnings Surprises & Stepwise Entry and Exit Trade Signals - Newser
Is TriSalus Life Sciences Inc. Equity Warrant currently under institutional pressure2025 Key Highlights & Smart Swing Trading Techniques - khodrobank.com
Can TriSalus Life Sciences Inc. be recession proofJuly 2025 Setups & Growth Oriented Trade Recommendations - khodrobank.com
Analyzing TriSalus Life Sciences Inc. with risk reward ratio charts2025 Price Targets & High Accuracy Trade Alerts - Newser
Key resistance and support levels for TriSalus Life Sciences Inc. Equity Warrant2025 Market Sentiment & Fast Moving Stock Trade Plans - Newser
What’s next for HCA Healthcare Inc. stock priceStock Surge & Scalable Portfolio Growth Ideas - Newser
Published on: 2025-08-31 15:12:23 - Newser
Ranking High Roller Technologies Inc. among high performing stocks via toolsWeekly Risk Report & AI Forecasted Entry and Exit Points - Newser
Forecasting TriSalus Life Sciences Inc. Equity Warrant price range with options dataTrade Risk Summary & Weekly High Return Stock Opportunities - Newser
What technical models suggest about TriSalus Life Sciences Inc.’s comebackGlobal Markets & Daily Price Action Insights - Newser
Trisalus Life Sciences Inc Azioni (TLSI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Trisalus Life Sciences Inc Azioni (TLSI) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Devlin Jodi | Chief of Clinical Operations |
May 19 '25 |
Sale |
5.18 |
4,764 |
24,678 |
52,764 |
| Marshak Richard | Chief Commercial Officer |
May 19 '25 |
Sale |
5.18 |
6,597 |
34,172 |
69,101 |
| Stevens Jennifer | Chief Regulatory Officer |
May 19 '25 |
Sale |
5.18 |
8,704 |
45,087 |
77,640 |
| Young James Emmett | Chief Financial Officer |
Feb 05 '25 |
Buy |
5.65 |
6,000 |
33,900 |
30,000 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
0.38%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):